Welcome to Globe Blotech Limited

An Innovative Biotech Company

LEARN MORE
Globe Blotech finally gets the nod to start human trials of BANGAVAX.
DNA in hands
About Our Company

Welcome to Globe Biotech Limited

Health is a universal human right, which is severely compromised for the high price of latest medications. Our objective is to provide 'QUALITY BIOLOGICS' at 'AFFORDABLE PRICE' for the 'GLOBAL POPULATION'.

We're also working for novel drug discovery for satisfying unmet medical conditions.

ISO 9001:2015
CERTIFIED
Globe
ISO 14001:2015
CERTIFIED
www.nature.com/scientificreports

scientific reports

OPEN
DoE-derived continuous and robust process for manufacturing of pharmaceutical-grade wide-range LNPs for RNA-vaccine/drug delivery
Kakon Nag1*, Md. Enaimul Haque1, Samir Kumar1, Habiba Khan1, Sonia Farhana1, Md. Rakib Hossain1, Md. Abdul Kader2, Md. Shahidur Rahman1, Farhana Khan1, Asif Mahmud1, Uttam Barman1, Elita Hossain Bhuiya1, Mohammad Mohiuddin1, Naznin Sultana1*
Liquid nanoparticle (LNP) technology has become extremely demanding for delivering RNA products including mRNA vaccines...
THE PREPRINT SERVER FOR BIOLOGY

bioRxiv

BANCOVID, the first D614G variant mRNA-based vaccine candidate against SARS-CoV-2 elicits neutralizing antibody and balanced cellular immune response
Baray, J. C., Khan, M. M. R., Mahmud, A., Islam, M. J., Myti, S., Ali, M. R., Sarker, M. E. H., Kumar, S., Chowdhury, M. M. H., Roy, R., Islam, F., Barman, U., Khan, H., Chakraborty, S., Hossain, M. M., Chowdhury, M. M. R., Ghosh, P., Mohiuddin, M., Sultana, N., Nag, K.
10.1101/2020.09.29.319061 — Posted: 2020-09-30
Effective vaccine technology against SARS-COV-2 developed by Globe Biotech Limited
view detail
Limited as marketing channel partner for the products, services and for facilitating to conduct clinical trials on various parts of the world.
view detail
2017
3 Biologics & Pre-Clinical Facility erection
Drug Discovery
Cell Therapy
Biologics
People
Place
Product
Policy

People Policy

Ensuring be and entrusting in family.

Product Policy

Quality from inception to consumption.

Pricing Policy

Affordable to all.

Place Policy

Proactive, risk-free and enjoyable.

People
Team member

Since 2016, Globe Biotech Ltd. have developed eight biosimilar drugs, which are under clinical trial and several more are under development. By the grace of Almighty Allah, we are proudly announcing that Globe Biotech Ltd. has developed a novel coronavirus vaccine for preventing COVID-19. We believe that this novel innovation will serve thousands of lives in Bangladesh and across the globe.

Place
R&D Facility
R&D Facility

R&D Facility Speciality

State of the art R&D facility with a scope to work in the field of Biologics, Regenerative Medicine, Cell Therapy, Immunotherapy, Gene Therapy etc. The department's mission to advance biopharmaceutical research beyond traditional boundaries is motivated by a passion for discovery and is well supported by other departments and contemporary facilities in Globe Biotech Limited.

OUR PRODUCTS

Aldesleukin
Filgrastim
Etanercept
Abatacept
Rilonacept
Adalimumab
Bevacizumab
Trastuzumab
Somatropin
Darbepoetin
Erythropoietin
Rituximab
Project

Our focus is to produce novel drugs and quality biologics. We are taking the pride to be the first company in Bangladesh that has started the journey with the vision to become a 'local discoverer and manufacturer' of biological drug substances (APIs) as well as finished products.

Cell Therapy
Gene Therapy
Diagnostic Kit
Vaccine
OUR LOCATION
3/Ka (new), Tejgaon I/A
Dhaka-1208, Bangladesh
+88 09609 777700
info@globe-blotech.com
Sat - Thu 24/7